CD8+ T cells are resistant to viral, bacterial infections, and even cell carcinogenesis (141), and CD8+ Tm cells maintain long-term antitumor activity through enhanced proliferative capacity, metabolic remodeling, and self-renewal capacity. The gene discussed is CD8A; the disease is bacterial infectious disease.